dmp 323 has been researched along with dmp 450 in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (80.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldrich, PE; Bacheler, LT; Chang, CH; Confalone, PN; Daneker, WF; DeLucca, GV; Emmett, G; Eyermann, CJ; Han, Q; Hodge, CN; Holler, ER; Jadhav, PK; Klabe, RM; Kornhauser, DM; Lam, PY; Li, L; Li, R; Markwalder, JA; McHugh, RJ; Rayner, MM; Ru, Y; Seitz, SP; Sharpe, TR; Shum, L; Winslow, DL | 1 |
| Ala, P; Anton, ED; Bacheler, LT; Chang, CH; Garber, SS; Jadhav, PK; Woerner, FJ | 1 |
| Cheatham, WW; Dax, S; Wilkerson, WW | 1 |
| Bacheler, LT; Calabrese, JC; Chang, CH; Daneker, WF; Erickson-Viitanen, S; Eyermann, CJ; Hodge, CN; Jackson, DA; Jadhav, PK; Lam, PY; Man, HW; Meek, JL; Rayner, MM; Schadt, M; Woerner, FJ | 1 |
| Bacheler, LT; Cordova, B; De Lucca, GV; Erickson-Viitanen, S; Garber, S; Kim, UT; Klabe, RM; Ko, SS; Lam, GN; Liang, J; Logue, KA; Trainor, GL; Wright, MR | 1 |
| Anderson, PS; Bacheler, LT; Chang, CH; Cordova, B; Erickson-Viitanen, S; Garber, S; Johnson, BL; Klabe, RM; Ko, SS; Lam, PY; Li, R; Reid, C; Rodgers, JD; Ru, Y; Seitz, SP; Trainor, GL; Wang, H; Wright, MR | 1 |
| Bacheler, LT; Cordova, BC; Erickson-Viitanen, S; Klabe, RM; Patel, M; Rayner, MM; Seitz, SP | 1 |
| Debnath, AK | 1 |
| Bacheler, LT; De Lucca, GV; Jacobs, K; Jadhav, PK; Kaltenbach, RF; Klabe, RM; Meyer, DT; Nugiel, DA; Patel, M; Rayner, MM; Seitz, SP; Smyser, TE; Worley, T | 1 |
| Ala, PJ; Chang, CH; DeLoskey, RJ; Duke, JL; Hodge, CN; Huston, EE; Klabe, RM; Korant, BD; Lam, PY; McCabe, DD; Rizzo, CJ | 1 |
| Ala, PJ; Chang, CH; DeLoskey, RJ; Duke, JL; Eyermann, CJ; Hodge, CN; Huston, EE; Jadhav, PK; Lam, PY; Lewandowski, FA; McCabe, DD; Schadt, MC; Weber, PC | 1 |
| Aungst, BJ; De Lucca, GV; Erickson-Viitanen, S; Jadhav, PK; Lam, PY; Waltermire, RE | 1 |
| Hylton, KG; Main, AD; McElwee-White, L | 1 |
| Sussman, F; Vilar, S; Villaverde, MC | 1 |
| Li, P; Wang, H; Wang, S; Yan, H | 1 |
1 review(s) available for dmp 323 and dmp 450
| Article | Year |
|---|---|
De novo design and discovery of cyclic HIV protease inhibitors capable of displacing the active-site structural water molecule.
Topics: Animals; Azepines; Binding Sites; Drug Design; HIV Protease; HIV Protease Inhibitors; Humans; Molecular Conformation; Urea | 1998 |
14 other study(ies) available for dmp 323 and dmp 450
| Article | Year |
|---|---|
Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas.
Topics: Animals; HIV Protease Inhibitors; Humans; Molecular Conformation; Structure-Activity Relationship; Urea | 1996 |
Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV.
Topics: Amides; Anti-HIV Agents; Cells, Cultured; Crystallography, X-Ray; Drug Resistance, Microbial; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Mutation; Protein Conformation; Sensitivity and Specificity; Urea | 1997 |
Nonsymmetrically substituted cyclic urea HIV protease inhibitors.
Topics: Anti-HIV Agents; HIV Protease Inhibitors; RNA, Viral; Structure-Activity Relationship; Urea | 1997 |
Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies.
Topics: Anti-HIV Agents; Cell Line; Crystallography, X-Ray; Guanidines; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Hydrogen Bonding; Models, Molecular; Structure-Activity Relationship; Urea | 1998 |
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Azepines; Biological Availability; Cell Line; Chromatography, High Pressure Liquid; Dogs; Drug Design; Drug Resistance, Microbial; HIV Protease Inhibitors; HIV-1; Indazoles; Mutation; Ritonavir; RNA, Viral; Structure-Activity Relationship; Transcription, Genetic; Urea | 1998 |
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors.
Topics: Animals; Anti-HIV Agents; Crystallography, X-Ray; Dogs; Drug Design; HIV; HIV Protease Inhibitors; Molecular Structure; Mutation; Protein Binding; Urea; Virus Replication | 1998 |
The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: modifications of the P1/P1' residues.
Topics: Antiviral Agents; Azepines; HIV; HIV Protease; HIV Protease Inhibitors; Indicators and Reagents; Kinetics; Molecular Structure; Structure-Activity Relationship; Urea | 1998 |
Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis.
Topics: Anti-HIV Agents; Crystallography, X-Ray; HIV Protease Inhibitors; Models, Molecular; Structure-Activity Relationship; Urea | 1999 |
Preparation and structure-activity relationship of novel P1/P1'-substituted cyclic urea-based human immunodeficiency virus type-1 protease inhibitors.
Topics: Azepines; Binding Sites; Cell Line; Cell Survival; Crystallography, X-Ray; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Molecular Structure; Protein Binding; Structure-Activity Relationship; Urea | 1996 |
Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors.
Topics: Azepines; Binding Sites; Crystallography, X-Ray; Drug Resistance, Microbial; HIV Protease; HIV Protease Inhibitors; Kinetics; Molecular Sequence Data; Mutagenesis, Insertional; Protein Conformation; Structure-Activity Relationship; Urea | 1997 |
Molecular recognition of cyclic urea HIV-1 protease inhibitors.
Topics: Anti-HIV Agents; Azepines; HIV Protease; HIV Protease Inhibitors; HIV-1; Hydrogen Bonding; Molecular Conformation; Urea | 1998 |
Catalytic carbonylation of functionalized diamines: application to the core structure of DMP 323 and DMP 450.
Topics: Azepines; Carbon Compounds, Inorganic; Catalysis; Diamines; HIV Protease Inhibitors; Molecular Structure; Tungsten; Urea | 2003 |
Inhibitor docking screened by the modified SAFE_p scoring function: application to cyclic urea HIV-1 PR inhibitors.
Topics: Algorithms; Amino Acids; Azepines; Binding Sites; Computer Simulation; HIV Protease; HIV Protease Inhibitors; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Molecular Structure; Protein Binding; Static Electricity; Thermodynamics; Urea | 2007 |
Synthesis and Biological Evaluation of 3,9-Dioxatetraasteranes as C
Topics: Azepines; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Docking Simulation; Structure-Activity Relationship; Urea; Urease | 2019 |